Cowen initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Get Rating) in a research report report published on Monday morning, Briefing.com reports. The firm issued an outperform rating on the stock. Several other research analysts also recently weighed in on the stock. SVB Leerink decreased their target price on shares of BridgeBio Pharma from […]